Connor, Clark & Lunn Investment Management Ltd. Haemonetics Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.1 Billion
- Q1 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Haemonetics Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 224,372 shares of HAE stock, worth $15.8 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
224,372
Previous 252,142
11.01%
Holding current value
$15.8 Million
Previous $19.7 Million
27.58%
% of portfolio
0.07%
Previous 0.1%
Shares
10 transactions
Others Institutions Holding HAE
# of Institutions
351Shares Held
53.3MCall Options Held
417KPut Options Held
314K-
Black Rock Inc. New York, NY5.96MShares$420 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$359 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$306 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$185 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$155 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.61B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...